Department of Clinical Laboratory, Hanzhong Central Hospital, 22 Kangfu Road, Hanzhong, Shaanxi, People's Republic of China.
BMC Infect Dis. 2024 Oct 9;24(1):1130. doi: 10.1186/s12879-024-10036-5.
The global threat of Carbapenem-resistant Acinetobacter baumannii (CRAB) has intensified as resistance to carbapenems continues to rise in recent decades. We aimed to explore risk factors, molecular epidemiology, and antimicrobial therapy of CRAB infection.
The clinical data of 110 patients infected with A. baumannii from December 2021 to December 2022 were retrospectively analyzed. Patients were divided into a carbapenem-resistance group (55 patients) and carbapenem-sensitive group (CSAB; 55 patients) based on resistance to carbapenem, and the risk factors of patients infected with CRAB were analyzed. Fifty-five patients with CRAB infection who received antimicrobial therapy were divided into a combination therapy group (45 patients) and a monotherapy group (10 patients), and differences between the two groups were compared. Whole-genome sequencing analysis was performed to assess resistance genes. Phylogenetic analysis was performed to explore the characteristics of CRAB isolates.
Among the total 110 patients, the rate of poor prognosis in the CRAB group was 43.6% (24/55). Mechanical ventilation (odds ratio [OR] = 5.364, 95% confidence interval [CI] 1.462-19.679, P = 0.011) and puncture (OR = 19.935, 95% CI 1.261-315.031, P = 0.012) were independent risk factors for CRAB infection. Of 55 patients in the antimicrobial regimen study, 45 received combination therapy (including dual, triple, or quadruple antibiotic therapy) and 10 received monotherapy. Univariate analysis revealed significant differences between the combination group and monotherapy group for admission to the intensive care unit and wound infection (P < 0.05). The CRAB strains of 26 patients taking carbapenem-based combination therapy were mainly ST208, ST1968, and ST195, among which patients with ST1968 strains had higher 28-day mortality. Furthermore, the bla gene was harbored in ST1968, ST195, and ST208.
Mortality was significantly higher in patients infected with CRAB than with CSAB. Mechanical ventilation and puncture were independent risk factors in predicting CRAB infections. The distribution of CRAB was dominated by ST208, ST1968, and ST195, among which patients with ST1968 had higher 28-day mortality. The bla gene appears to be widely disseminated.
近年来,碳青霉烯类耐药鲍曼不动杆菌(CRAB)的全球威胁加剧,碳青霉烯类耐药率不断上升。本研究旨在探讨 CRAB 感染的危险因素、分子流行病学和抗菌治疗。
回顾性分析 2021 年 12 月至 2022 年 12 月期间 110 例感染鲍曼不动杆菌的患者的临床资料。根据对碳青霉烯类药物的耐药性,将患者分为碳青霉烯耐药组(55 例)和碳青霉烯敏感组(CSAB;55 例),分析 CRAB 感染患者的危险因素。对 55 例接受抗菌治疗的 CRAB 感染患者进行分析,根据抗菌治疗方案的不同,将其分为联合治疗组(45 例)和单药治疗组(10 例),比较两组间的差异。进行全基因组测序分析以评估耐药基因。进行系统发育分析以探讨 CRAB 分离株的特征。
在 110 例患者中,CRAB 组的预后不良率为 43.6%(24/55)。机械通气(比值比 [OR] = 5.364,95%置信区间 [CI] 1.462-19.679,P = 0.011)和穿刺(OR = 19.935,95% CI 1.261-315.031,P = 0.012)是 CRAB 感染的独立危险因素。在接受抗菌治疗方案研究的 55 例患者中,45 例接受联合治疗(包括双联、三联或四联抗生素治疗),10 例接受单药治疗。单因素分析显示,联合治疗组与单药治疗组在入住重症监护病房和伤口感染方面存在显著差异(P < 0.05)。26 例接受碳青霉烯类联合治疗的患者的 CRAB 菌株主要为 ST208、ST1968 和 ST195,其中 ST1968 菌株患者的 28 天死亡率较高。此外,bla 基因存在于 ST1968、ST195 和 ST208 中。
与 CSAB 感染相比,CRAB 感染患者的死亡率显著更高。机械通气和穿刺是预测 CRAB 感染的独立危险因素。CRAB 的分布主要以 ST208、ST1968 和 ST195 为主,其中 ST1968 菌株患者的 28 天死亡率较高。bla 基因似乎广泛传播。